Cisapride in Constipation
Yvan Vandenplas
Abstract
Yvan Vandenplas
Abstract
To the Editor: I. M. Halabi showed that cisapride may be helpful in the management of chronic idiopathic constipation in children (1). However, cisapride should not be recommended as a first-line approach in paediatric constipation. Prokinetics, or drug treatment in general, should only be recommended after failure of behavioral (physical activity) and dietary changes (Fluid, fiber, fruit) (2). Moreover, the dose of cisapride used in the study by Halabi (1.2 mg/kg/day) is 50% above the recommended safe dose of 0.8 mg/kg per day (3). If cisapride is prescribed in a dose higher than the recommended 0.8 mg/kg per day, safety procedures such as an electrocardiogram 48 to 72 hours after initiation of cisapride at a higher dose should be performed (3). Yvan Vandenplas AZ-VUB, Laarbeeklaan Brussels, Belgium
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To the Editor: I. M. Halabi showed that cisapride may be helpful in the management of chronic idiopathic constipation in children (1). However, cisapride should not be recommended as a first-line approach in paediatric constipation. Prokinetics, or drug treatment in general, should only be recommended after failure of behavioral (physical activity) and dietary changes (Fluid, fiber, fruit) (2). Moreover, the dose of cisapride used in the study by Halabi (1.2 mg/kg/day) is 50% above the recommended safe dose of 0.8 mg/kg per day (3). If cisapride is prescribed in a dose higher than the recommended 0.8 mg/kg per day, safety procedures such as an electrocardiogram 48 to 72 hours after initiation of cisapride at a higher dose should be performed (3). Yvan Vandenplas AZ-VUB, Laarbeeklaan Brussels, Belgium
Key concepts: Cisapride, Medicine, Constipation, Prokinetic agent, Drug, Internal medicine, Gastroenterology, Anesthesia